BioMEL- Diagnostic and Prognostic Factors in Melanoma. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BioMEL- Diagnostic and Prognostic Factors in Melanoma. — Stella

Recruiting

Back to Melanoma trials

Trial locations(4 sites)

Sweden

Helsingborg Hospital, Helsingborg, Skåne County

Kristianstad Hospital, Kristianstad, Skåne County

Lund University Hospital, Lund, Skåne County

Skåne University Hospital Malmö, Malmo, Skåne County

Key details

Sponsor

Region Skane

Enrollment target

~2,000 participants

Started

November 2013

Primary completion

December 2026

Age range

18 Years and older

Last updated January 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov